OK Bill the reason there wasn't a lot of exiting new info is because only a month ago they announced a record month and the additional revenue growth info was already released via the MacQuarie presentation last week. If that info was held back until today it would have "seemed" bigger. As for there new CEO, yes perhaps they could of mentioned that but I'll assume nothing new to report. BUT didn't you pick up on the Beta Cell talk? That fact that Coates couldn't say a lot regarding partners until his paper is released in a couple of weeks? The fact Novo Nordisk (massive company) told DW every company like them will need a delivery system like PNVs? That fact this is a new/additional business for PNV? This is not "cheap talk". This is happening right now. Don't be surprised if PNV acquire Beta Cell just like they acquired Novoskin (Greenwood/Burton company) about 10 years ago. I think that was in exchange for about 18m shares. So hang in there. Things are looking great going forward imo.
PNV Price at posting:
$1.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)